Investig Clin Urol.  2019 Jul;60(4):225-226. 10.4111/icu.2019.60.4.225.

Are we ready to adopt the European Association of Urology recommendations on multiparametric magnetic resonance imaging in the early detection of prostate cancer?

• Thangasamy IA
• Alghazo O
• Murphy DG

• KMID: 2450538
• DOI: http://doi.org/10.4111/icu.2019.60.4.225

Abstract

No abstract available.

MeSH Terms

Magnetic Resonance Imaging*
Prostate*
Prostatic Neoplasms*
Urology*

Reference

1. Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines: EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Arnhem: EAU Guidelines Office;2019.

2. Murphy DG, Padhani AR, Ost P. Adding colour to the grey zone of advanced prostate cancer. Eur Urol Focus. 2019; 5:123–124.

3. Nzenza T, Murphy DG. PRECISION delivers on the PROMIS of mpMRI in early detection. Nat Rev Urol. 2018; 15:529–530.

4. Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017; 389:815–822.

5. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018; 378:1767–1777.

6. Porpiglia F, Manfredi M, Mele F, Cossu M, Bollito E, Veltri A, et al. Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a randomized prospective study in biopsy-naïve patients with suspected prostate cancer. Eur Urol. 2017; 72:282–288.